Albert C Kao, MD
Nephrology · Daly City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 3 carriers
- Office
- 1
- Since medical school
- 26 years
- Yale University School of Medicine, 2000
Offices
1 location · West Coast Kidney · 56 clinicians in this group
Looking this up.
Hospitals listed: 552682 · 552878 · 752538 · Ahmc Seton Medical Center · Mills-Peninsula Medical Center · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
19 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kao’s office at (650) 755-4490 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A75956 · Current
Licensed to practise in California · since 2001 · expires 2027-04-30 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Peninsula dialysis access centerAmbulatory Surgery Center · South San Francisco, CA6% owner since 2024 · accredited by HFAPInitial Accreditation1 inspection, 1 with deficiencies · last 2025-07-29
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ahmc Seton Medical CenterDaly City, CAAcute Care Hospital · Proprietary · Has an emergency departmentPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Ahmc Seton Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.04) · 229 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.49 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.5 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.9 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 1,636 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 1,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.1 to 4.43) · 361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.62 (0 to 18.38) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.98 (1.71 to 10.25) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 77 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.4 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 258 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 48 cases | No different | Jan 2022 – Dec 2024 |
What patients said (257 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$331,818
Medicare paid this office $331,818 for 514 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 53 | $78,747 | $310 |
| Home dialysis services per month (20 years or older) | 19 | $48,168 | $258 |
| Return visit (30+ min) | 201 | $39,880 | $103 |
| Long return visit (40+ min) | 135 | $34,968 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $26,736 | $103 |
See all 18 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 53 | $78,747 | $310 |
| Home dialysis services per month (20 years or older) | 19 | $48,168 | $258 |
| Return visit (30+ min) | 201 | $39,880 | $103 |
| Long return visit (40+ min) | 135 | $34,968 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $26,736 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $15,956 | $69 |
| Critical care, first 30-74 minutes | 42 | $15,421 | $184 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 60 | $12,787 | $59 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 21 | $11,499 | $256 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $9,785 | $146 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 239 | $7,869 | $14 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 61 | $6,808 | $46 |
| New patient visit (60+ min) | 32 | $5,945 | $186 |
| Transitional care management services for problem of at least moderate complexity | 14 | $3,011 | $201 |
| Hemodialysis procedure with physician evaluation | 30 | $2,375 | $61 |
| Advance care planning, first 30 minutes | 23 | $2,091 | $67 |
| Advance care planning, first 30 minutes | 11 | $1,134 | $76 |
| Dialysis procedure including 1 evaluation | 11 | $1,093 | $78 |
Who their Medicare patients are
514 Original Medicare patients in 2024. Average age 77 · Under 65 11% · 85 and older 26% · Women 44% · Also on Medicaid 24% · Health risk score 4.12. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 61% · Heart failure 50% · Coronary heart disease 48% · Atrial fibrillation 42% · Cancer 22% · Depression 22% · COPD 19% · Stroke 19% · Dementia 18%.
The office billed $902,304, Medicare allowed $430,437 and paid $331,818; for 2,870 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 514 | 2,870 | 77 | 4.12 | $902,304 | $331,818 |
| 2023 | 477 | 1,843 | 77 | 4.08 | $780,620 | $275,188 |
| 2022 | 492 | 2,075 | 76 | 4.06 | $930,104 | $328,218 |
| 2021 | 514 | 2,289 | 76 | 4.11 | $1,030,340 | $400,181 |
| 2020 | 572 | 2,791 | 75 | 5.05 | $1,245,361 | $479,232 |
| 2019 | 624 | 3,038 | 76 | 4.47 | $1,135,582 | $428,786 |
| 2018 | 590 | 2,929 | 75 | 4.52 | $1,310,109 | $423,037 |
| 2017 | 591 | 2,929 | 74 | 4.79 | $1,487,181 | $386,839 |
| 2016 | 513 | 2,556 | 75 | 4.11 | $1,211,251 | $322,740 |
| 2015 | 478 | 2,562 | 75 | 4.23 | $1,107,315 | $293,972 |
| 2014 | 507 | 2,812 | 76 | 3.96 | $1,155,534 | $307,432 |
| 2013 | 467 | 2,504 | 74 | 4.21 | $1,083,567 | $279,557 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 52 | $71,377 | $317 |
| Home dialysis services per month (20 years or older) | 21 | $45,621 | $259 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 126 | $27,559 | $102 |
| Critical care, first 30-74 minutes | 65 | $27,473 | $188 |
| Return visit (30+ min) | 184 | $26,608 | $62 |
| Long return visit (40+ min) | 95 | $25,628 | $158 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 17 | $13,830 | $271 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 84 | $9,713 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $7,914 | $152 |
| New patient visit (60+ min) | 30 | $6,131 | $204 |
| Hemodialysis procedure with physician evaluation | 24 | $2,970 | $65 |
2022: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 77 | $121,882 | $322 |
| Home dialysis services per month (20 years or older) | 28 | $57,370 | $264 |
| Long return visit (40+ min) | 104 | $23,918 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 128 | $21,108 | $64 |
| Return visit (30+ min) | 170 | $18,206 | $52 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $17,035 | $262 |
| Critical care, first 30-74 minutes | 44 | $16,600 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 108 | $15,912 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $10,512 | $178 |
| New patient visit (60+ min) | 38 | $7,567 | $199 |
| Hemodialysis procedure with physician evaluation | 38 | $3,871 | $60 |
| Dialysis procedure including 1 evaluation | 15 | $2,382 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $1,973 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,724 | $123 |
2021: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 90 | $158,966 | $320 |
| Home dialysis services per month (20 years or older) | 23 | $61,826 | $269 |
| Return visit (30+ min) | 158 | $32,333 | $113 |
| Long return visit (40+ min) | 118 | $27,637 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 140 | $25,108 | $64 |
| Critical care, first 30-74 minutes | 50 | $22,644 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 115 | $17,099 | $93 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 25 | $13,374 | $262 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $11,076 | $179 |
| New patient visit (60+ min) | 39 | $7,735 | $198 |
| Hemodialysis procedure with physician evaluation | 43 | $4,166 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,323 | $116 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 15 | $2,105 | $39 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $1,128 | $56 |
2020: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 198 | $284,819 | $259 |
| Home dialysis services per month (20 years or older) | 24 | $50,360 | $220 |
| Critical care, first 30-74 minutes | 43 | $20,001 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 136 | $18,732 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 108 | $18,588 | $95 |
| Return visit (30+ min) | 139 | $17,302 | $84 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $15,095 | $222 |
| Long return visit (40+ min) | 84 | $14,520 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $12,011 | $182 |
| Telephone medical discussion with physician, 21-30 minutes | 57 | $8,107 | $105 |
| Hemodialysis procedure with physician evaluation | 43 | $3,760 | $65 |
| Hemodialysis procedure requiring repeated evaluation | 19 | $2,592 | $96 |
| New patient visit (60+ min) | 13 | $2,125 | $163 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,504 | $125 |
| Short return visit (20+ min) | 12 | $753 | $63 |
2019: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 108 | $170,393 | $255 |
| Critical care, first 30-74 minutes | 99 | $45,981 | $197 |
| Home dialysis services per month (20 years or older) | 23 | $42,707 | $216 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 230 | $35,492 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $24,093 | $180 |
| Return visit (30+ min) | 173 | $23,957 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 135 | $23,334 | $93 |
| Long return visit (40+ min) | 82 | $16,095 | $129 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 41 | $13,868 | $210 |
| Hemodialysis procedure with physician evaluation | 84 | $11,607 | $66 |
| New patient visit (60+ min) | 24 | $4,316 | $180 |
| Hemodialysis procedure requiring repeated evaluation | 19 | $2,461 | $91 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $2,183 | $168 |
| Critical care, each additional 30 minutes | 16 | $1,975 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,599 | $114 |
2018: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 107 | $160,126 | $254 |
| Critical care, first 30-74 minutes | 94 | $51,889 | $194 |
| Home dialysis services per month (20 years or older) | 20 | $37,718 | $208 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 207 | $30,278 | $63 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 61 | $26,335 | $214 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 132 | $25,784 | $177 |
| Long return visit (40+ min) | 100 | $18,477 | $125 |
| Hemodialysis procedure with physician evaluation | 103 | $17,104 | $64 |
| Return visit (30+ min) | 137 | $16,401 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 98 | $14,947 | $90 |
| New patient visit (60+ min) | 55 | $10,197 | $185 |
| Dialysis services, 1 physician visit per month (20 years or older) | 18 | $3,192 | $168 |
| Urinalysis, manual test | 16 | $55 | $3 |
2017: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 125 | $149,542 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 233 | $37,187 | $64 |
| Critical care, first 30-74 minutes | 81 | $35,284 | $195 |
| Home dialysis services per month (20 years or older) | 16 | $30,567 | $214 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $26,327 | $177 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 64 | $21,595 | $212 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 116 | $18,976 | $93 |
| Long return visit (40+ min) | 101 | $18,381 | $126 |
| Hemodialysis procedure with physician evaluation | 103 | $16,198 | $64 |
| Return visit (30+ min) | 122 | $14,873 | $88 |
| New patient visit (60+ min) | 44 | $8,258 | $188 |
| Critical care, each additional 30 minutes | 11 | $1,371 | $98 |
| Urinalysis, manual test | 35 | $120 | $3 |
2016: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 54 | $106,194 | $257 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 172 | $31,784 | $64 |
| Home dialysis services per month (20 years or older) | 20 | $29,350 | $214 |
| Critical care, first 30-74 minutes | 64 | $28,425 | $195 |
| Long return visit (40+ min) | 118 | $23,061 | $130 |
| Return visit (30+ min) | 140 | $20,306 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 100 | $19,899 | $179 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $18,299 | $215 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $12,601 | $93 |
| New patient visit (60+ min) | 65 | $11,538 | $178 |
| Hemodialysis procedure with physician evaluation | 75 | $10,018 | $65 |
| Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour | 17 | $447 | $19 |
| Urinalysis, manual test | 34 | $116 | $3 |
2015: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 51 | $84,225 | $257 |
| Critical care, first 30-74 minutes | 69 | $33,794 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 187 | $30,461 | $65 |
| Home dialysis services per month (20 years or older) | 16 | $26,700 | $210 |
| Return visit (30+ min) | 160 | $25,123 | $91 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 39 | $20,917 | $218 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $19,490 | $172 |
| Long return visit (40+ min) | 82 | $14,645 | $127 |
| Hemodialysis procedure with physician evaluation | 75 | $10,574 | $64 |
| New patient visit (60+ min) | 40 | $7,331 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $7,083 | $93 |
| Dialysis procedure including 1 evaluation | 15 | $3,900 | $78 |
| Dialysis services, per day, less than full month service (20 years or older) | 11 | $3,163 | $7 |
| Manual urinalysis test with examination using microscope, non-automated | 26 | $110 | $4 |
2014: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 40 | $73,857 | $256 |
| Critical care, first 30-74 minutes | 65 | $43,390 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 221 | $36,423 | $64 |
| Return visit (30+ min) | 177 | $29,901 | $95 |
| Home dialysis services per month (20 years or older) | 18 | $28,857 | $215 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 125 | $24,669 | $180 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $19,103 | $212 |
| Hemodialysis procedure with physician evaluation | 87 | $15,877 | $65 |
| New patient visit (60+ min) | 45 | $8,159 | $181 |
| Long return visit (40+ min) | 46 | $7,328 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $7,031 | $93 |
| Dialysis services, per day, less than full month service (20 years or older) | 11 | $3,386 | $7 |
| Dialysis procedure including 1 evaluation | 11 | $3,356 | $78 |
| Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour | 14 | $523 | $20 |
| Manual urinalysis test with examination using microscope, non-automated | 33 | $140 | $4 |
2013: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 41 | $71,243 | $254 |
| Critical care, first 30-74 minutes | 77 | $35,991 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 205 | $32,230 | $62 |
| Return visit (30+ min) | 154 | $28,259 | $88 |
| Home dialysis services per month (20 years or older) | 17 | $26,968 | $214 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 107 | $21,446 | $173 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 28 | $21,249 | $215 |
| Hemodialysis procedure with physician evaluation | 106 | $18,148 | $62 |
| New patient visit (60+ min) | 30 | $5,400 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $3,956 | $90 |
| Long return visit (40+ min) | 23 | $3,150 | $126 |
| Dialysis services, per day, less than full month service (20 years or older) | 12 | $2,342 | $7 |
| Dialysis services, 1 physician visit per month (20 years or older) | 11 | $1,847 | $168 |
| Manual urinalysis test with examination using microscope, non-automated | 16 | $68 | $4 |
Medicaid work
$42,116 in 2024
Medicaid paid $42,116 for 374 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 200 | $36,731 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 72 | $2,939 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 61 | $2,270 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 41 | $176 |
| 2024 | 374 | 4 | 25 | $42,116 |
| 2023 | 244 | 3 | 23 | $33,334 |
| 2022 | 363 | 3 | 28 | $30,454 |
| 2021 | 524 | 4 | 33 | $27,251 |
| 2020 | 1,043 | 4 | 124 | $66,485 |
| 2019 | 874 | 5 | 33 | $29,866 |
| 2018 | 310 | 4 | 27 | $17,121 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 193 | $31,212 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 29 | $1,079 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 22 | $1,043 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 265 | $27,524 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 81 | $1,909 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 17 | $1,021 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 294 | $22,230 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 144 | $2,590 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 74 | $2,067 |
| Long return visit (40+ min) | 12 | $364 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 747 | $60,293 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 196 | $3,103 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 86 | $2,647 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 14 | $442 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 314 | $21,055 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 402 | $5,326 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 87 | $1,816 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 44 | $911 |
| 1ST HOSP IP/OBS HIGH 75 | 27 | $758 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 136 | $12,960 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 145 | $2,999 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $626 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 17 | $535 |
Drugs they prescribed that Part D paid
$785,838
Pharmacies billed $785,838 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,887) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
2,424 generic and 463 brand-name prescriptions · $785,838 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 275 | $397,536 | $1,446 |
| Velphoro | 18 | $110,096 | $6,116 |
| Sevelamer Carbonate | 94 | $66,718 | $710 |
| Jardiance | 32 | $43,810 | $1,369 |
| Veltassa | 22 | $34,673 | $1,576 |
See all 40 drugs
| Farxiga | 275 | $397,536 | $1,446 |
| Velphoro | 18 | $110,096 | $6,116 |
| Sevelamer Carbonate | 94 | $66,718 | $710 |
| Jardiance | 32 | $43,810 | $1,369 |
| Veltassa | 22 | $34,673 | $1,576 |
| Dapagliflozin | 29 | $14,202 | $490 |
| Retacrit | 11 | $9,390 | $854 |
| Sps | 14 | $4,056 | $290 |
| Atorvastatin | 271 | $3,954 | $15 |
| Irbesartan | 156 | $3,637 | $23 |
| Chlorthalidone | 182 | $3,129 | $17 |
| Prosol | 21 | $2,596 | $124 |
| Calcium Acetate | 35 | $2,592 | $74 |
| Amlodipine Besylate | 355 | $2,439 | $7 |
| Bumetanide | 35 | $2,366 | $68 |
| Torsemide | 71 | $2,332 | $33 |
| Nifedipine Er | 59 | $2,242 | $38 |
| Hydralazine | 96 | $2,196 | $23 |
| Metoprolol | 114 | $1,980 | $17 |
| Telmisartan | 48 | $1,686 | $35 |
| Rosuvastatin | 48 | $1,453 | $30 |
| Furosemide | 126 | $1,083 | $9 |
| Benazepril | 72 | $1,082 | $15 |
| Ezetimibe | 21 | $1,015 | $48 |
| Calcitriol | 46 | $843 | $18 |
| Carvedilol | 45 | $792 | $18 |
| Pravastatin | 40 | $640 | $16 |
| Sodium Polystyrene Sulfonate | 13 | $523 | $40 |
| Lidocaine-Prilocaine | 19 | $474 | $25 |
| Allopurinol | 46 | $399 | $9 |
| Lisinopril | 72 | $383 | $5 |
| Valsartan | 18 | $359 | $20 |
| Losartan | 45 | $347 | $8 |
| Hydrochlorothiazide | 43 | $331 | $8 |
| Labetalol | 16 | $312 | $19 |
| Gabapentin | 16 | $307 | $19 |
| Triamterene-Hydrochlorothiazid | 34 | $250 | $7 |
| Potassium Chloride | 14 | $173 | $12 |
| Simvastatin | 14 | $109 | $8 |
| Metoprolol | 14 | $107 | $8 |
Year by year
| 2024 | 2,887 | 425 | 0% (0) | 16% | $785,838 |
| 2023 | 2,710 | 402 | 0% (0) | 13% | $657,304 |
| 2022 | 2,710 | 398 | 0% (0) | 16% | $591,453 |
| 2021 | 2,616 | 362 | 0% (0) | None | $414,486 |
| 2020 | 2,412 | 357 | None | 20% | $465,246 |
| 2019 | 2,225 | 347 | None | 21% | $448,036 |
| 2018 | 2,380 | 342 | None | 23% | $465,627 |
| 2017 | 2,614 | 321 | None | 29% | $1,141,074 |
| 2016 | 2,518 | 308 | 1% (12) | None | $926,141 |
| 2015 | 2,367 | 284 | 1% (26) | None | $879,220 |
| 2014 | 2,655 | 278 | 2% (44) | None | $791,084 |
| 2013 | 2,821 | 271 | 2% (54) | None | $653,623 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Farxiga | 156 | $245,904 | $1,576 |
| Velphoro | 16 | $88,484 | $5,530 |
| Renvela | 11 | $62,456 | $5,678 |
| Jardiance | 34 | $47,908 | $1,409 |
| Sevelamer Carbonate | 104 | $47,634 | $458 |
| Veltassa | 17 | $20,012 | $1,177 |
| Irbesartan | 161 | $6,845 | $43 |
| Prosol | 39 | $5,539 | $142 |
| Atorvastatin | 264 | $5,234 | $20 |
| Chlorthalidone | 202 | $4,834 | $24 |
| Amlodipine Besylate | 343 | $4,330 | $13 |
| Calcium Acetate | 32 | $4,134 | $129 |
| Bumetanide | 43 | $3,921 | $91 |
| Torsemide | 98 | $3,262 | $33 |
| Midodrine | 15 | $3,219 | $215 |
| Hydralazine | 104 | $2,924 | $28 |
| Sps | 13 | $2,842 | $219 |
| Metoprolol | 108 | $2,731 | $25 |
| Nifedipine Er | 41 | $2,668 | $65 |
| Telmisartan | 24 | $2,438 | $102 |
| Clinisol | 16 | $2,057 | $129 |
| Furosemide | 122 | $1,829 | $15 |
| Calcitriol | 64 | $1,649 | $26 |
| Benazepril | 65 | $1,639 | $25 |
| Rosuvastatin | 35 | $1,584 | $45 |
| Lidocaine-Prilocaine | 21 | $1,119 | $53 |
| Lisinopril | 76 | $1,110 | $15 |
| Carvedilol | 49 | $946 | $19 |
| Allopurinol | 39 | $915 | $23 |
| Valsartan | 18 | $552 | $31 |
| Labetalol | 19 | $456 | $24 |
| Hydrochlorothiazide | 34 | $369 | $11 |
| Nystatin | 17 | $306 | $18 |
| Losartan | 25 | $304 | $12 |
| Triamterene-Hydrochlorothiazid | 19 | $290 | $15 |
| Terazosin | 12 | $285 | $24 |
| Potassium Chloride | 13 | $234 | $18 |
| Pravastatin | 27 | $211 | $8 |
| Atenolol | 11 | $156 | $14 |
| Simvastatin | 11 | $106 | $10 |
2022: 39 drugs
| Farxiga | 86 | $127,198 | $1,479 |
| Velphoro | 29 | $97,099 | $3,348 |
| Sevelamer Carbonate | 99 | $62,018 | $626 |
| Renvela | 13 | $55,970 | $4,305 |
| Prosol | 147 | $33,576 | $228 |
| Veltassa | 27 | $30,092 | $1,115 |
| Jardiance | 22 | $22,090 | $1,004 |
| Retacrit | 15 | $11,227 | $748 |
| Irbesartan | 139 | $6,445 | $46 |
| Bumetanide | 60 | $5,145 | $86 |
| Atorvastatin | 258 | $4,901 | $19 |
| Chlorthalidone | 204 | $4,303 | $21 |
| Torsemide | 100 | $4,126 | $41 |
| Amlodipine Besylate | 317 | $3,496 | $11 |
| Metoprolol | 127 | $3,342 | $26 |
| Calcium Acetate | 21 | $3,017 | $144 |
| Hydralazine | 110 | $2,530 | $23 |
| Nifedipine Er | 29 | $2,177 | $75 |
| Lidocaine-Prilocaine | 18 | $2,132 | $118 |
| Furosemide | 147 | $1,843 | $13 |
| Sodium Polystyrene Sulfonate | 19 | $1,732 | $91 |
| Benazepril | 84 | $1,704 | $20 |
| Calcitriol | 76 | $1,655 | $22 |
| Telmisartan | 20 | $1,376 | $69 |
| Rosuvastatin | 41 | $1,236 | $30 |
| Carvedilol | 45 | $894 | $20 |
| Valsartan | 23 | $860 | $37 |
| Allopurinol | 36 | $766 | $21 |
| Pravastatin | 31 | $692 | $22 |
| Labetalol | 15 | $662 | $44 |
| Losartan | 22 | $393 | $18 |
| Lisinopril | 31 | $340 | $11 |
| Potassium Chloride | 16 | $263 | $16 |
| Nystatin | 11 | $257 | $23 |
| Triamterene-Hydrochlorothiazid | 18 | $176 | $10 |
| Terazosin | 13 | $160 | $12 |
| Hydrochlorothiazide | 17 | $146 | $9 |
| Atenolol | 12 | $61 | $5 |
| Simvastatin | 11 | $30 | $3 |
2021: 33 drugs
| Renvela | 22 | $59,743 | $2,716 |
| Velphoro | 22 | $46,938 | $2,134 |
| Sevelamer Carbonate | 125 | $43,855 | $351 |
| Farxiga | 27 | $35,192 | $1,303 |
| Prosol | 179 | $30,743 | $172 |
| Veltassa | 24 | $25,660 | $1,069 |
| Clinolipid | 80 | $19,481 | $244 |
| Jardiance | 15 | $16,413 | $1,094 |
| Bumetanide | 58 | $6,598 | $114 |
| Irbesartan | 141 | $6,204 | $44 |
| Atorvastatin | 255 | $4,697 | $18 |
| Calcium Acetate | 42 | $4,168 | $99 |
| Metoprolol | 120 | $3,692 | $31 |
| Chlorthalidone | 121 | $3,225 | $27 |
| Torsemide | 80 | $3,067 | $38 |
| Amlodipine Besylate | 282 | $2,824 | $10 |
| Hydralazine | 101 | $2,590 | $26 |
| Furosemide | 170 | $2,293 | $13 |
| Calcitriol | 72 | $1,846 | $26 |
| Nifedipine Er | 28 | $1,747 | $62 |
| Benazepril | 99 | $1,624 | $16 |
| Telmisartan | 20 | $1,377 | $69 |
| Carvedilol | 61 | $1,126 | $18 |
| Rosuvastatin | 34 | $1,037 | $31 |
| Lidocaine-Prilocaine | 19 | $1,002 | $53 |
| Losartan | 35 | $767 | $22 |
| Allopurinol | 39 | $757 | $19 |
| Pravastatin | 31 | $605 | $20 |
| Potassium Chloride | 16 | $331 | $21 |
| Lisinopril | 22 | $248 | $11 |
| Atenolol | 14 | $197 | $14 |
| Hydrochlorothiazide | 22 | $171 | $8 |
| Simvastatin | 12 | $74 | $6 |
2020: 37 drugs
| Sevelamer Carbonate | 147 | $89,943 | $612 |
| Renvela | 21 | $88,200 | $4,200 |
| Velphoro | 31 | $86,993 | $2,806 |
| Veltassa | 25 | $34,971 | $1,399 |
| Prosol | 183 | $27,430 | $150 |
| Bumetanide | 44 | $5,050 | $115 |
| Chlorthalidone | 129 | $5,038 | $39 |
| Clinolipid | 18 | $4,431 | $246 |
| Calcium Acetate | 45 | $4,376 | $97 |
| Febuxostat | 13 | $4,115 | $317 |
| Atorvastatin | 234 | $4,106 | $18 |
| Cinacalcet | 12 | $3,782 | $315 |
| Irbesartan | 93 | $3,708 | $40 |
| Telmisartan | 31 | $3,494 | $113 |
| Torsemide | 66 | $3,381 | $51 |
| Intralipid | 13 | $2,930 | $225 |
| Calcitriol | 73 | $2,409 | $33 |
| Metoprolol | 85 | $2,348 | $28 |
| Amlodipine Besylate | 268 | $2,300 | $9 |
| Hydralazine | 105 | $2,006 | $19 |
| Furosemide | 175 | $1,990 | $11 |
| Benazepril | 104 | $1,534 | $15 |
| Rosuvastatin | 38 | $1,504 | $40 |
| Lidocaine-Prilocaine | 22 | $1,404 | $64 |
| Losartan | 45 | $1,008 | $22 |
| Valsartan | 13 | $857 | $66 |
| Nifedipine Er | 20 | $852 | $43 |
| Allopurinol | 37 | $816 | $22 |
| Ezetimibe | 11 | $703 | $64 |
| Carvedilol | 41 | $667 | $16 |
| Pravastatin | 30 | $652 | $22 |
| Lisinopril | 19 | $282 | $15 |
| Simvastatin | 22 | $257 | $12 |
| Clonidine | 15 | $226 | $15 |
| Triamterene-Hydrochlorothiazid | 13 | $115 | $9 |
| Metoprolol | 11 | $99 | $9 |
| Hydrochlorothiazide | 16 | $75 | $5 |
2019: 34 drugs
| Velphoro | 38 | $104,075 | $2,739 |
| Sevelamer Carbonate | 127 | $103,582 | $816 |
| Renvela | 17 | $39,387 | $2,317 |
| Prosol | 208 | $29,953 | $144 |
| Veltassa | 18 | $20,052 | $1,114 |
| Intralipid | 47 | $11,032 | $235 |
| Bumetanide | 51 | $5,972 | $117 |
| Chlorthalidone | 114 | $4,929 | $43 |
| Atorvastatin | 222 | $4,634 | $21 |
| Irbesartan | 65 | $3,444 | $53 |
| Metoprolol | 65 | $2,199 | $34 |
| Amlodipine Besylate | 207 | $2,177 | $11 |
| Calcitriol | 44 | $1,775 | $40 |
| Furosemide | 175 | $1,755 | $10 |
| Torsemide | 37 | $1,582 | $43 |
| Hydralazine | 75 | $1,537 | $20 |
| Telmisartan | 25 | $1,503 | $60 |
| Calcium Acetate | 23 | $1,490 | $65 |
| Losartan | 61 | $1,149 | $19 |
| Benazepril | 83 | $1,129 | $14 |
| Lidocaine-Prilocaine | 21 | $1,002 | $48 |
| Pravastatin | 35 | $980 | $28 |
| Rosuvastatin | 21 | $845 | $40 |
| Valsartan | 11 | $827 | $75 |
| Carvedilol | 49 | $704 | $14 |
| Tacrolimus | 12 | $677 | $56 |
| Allopurinol | 30 | $652 | $22 |
| Potassium Chloride | 14 | $461 | $33 |
| Lisinopril | 33 | $330 | $10 |
| Simvastatin | 29 | $310 | $11 |
| Lovastatin | 11 | $197 | $18 |
| Metoprolol | 14 | $156 | $11 |
| Hydrochlorothiazide | 15 | $112 | $7 |
| Triamterene-Hydrochlorothiazid | 11 | $110 | $10 |
2018: 42 drugs
| Sevelamer Carbonate | 105 | $136,734 | $1,302 |
| Renvela | 37 | $110,780 | $2,994 |
| Prosol | 258 | $38,688 | $150 |
| Velphoro | 24 | $28,655 | $1,194 |
| Intralipid | 61 | $12,118 | $199 |
| Uloric | 12 | $11,282 | $940 |
| Atorvastatin | 200 | $5,845 | $29 |
| Bumetanide | 45 | $5,691 | $126 |
| Chlorthalidone | 114 | $5,108 | $45 |
| Irbesartan | 79 | $3,201 | $41 |
| Metoprolol | 66 | $2,629 | $40 |
| Potassium Chloride | 12 | $2,502 | $209 |
| Amlodipine Besylate | 196 | $2,229 | $11 |
| Calcitriol | 54 | $2,163 | $40 |
| Calcium Acetate | 18 | $1,427 | $79 |
| Hydralazine | 70 | $1,360 | $19 |
| Rosuvastatin | 18 | $1,349 | $75 |
| Pravastatin | 49 | $1,191 | $24 |
| Furosemide | 143 | $1,175 | $8 |
| Torsemide | 36 | $1,079 | $30 |
| Valsartan | 13 | $979 | $75 |
| Nifedipine Er | 11 | $956 | $87 |
| Losartan | 56 | $936 | $17 |
| Allopurinol | 30 | $908 | $30 |
| Lidocaine-Prilocaine | 33 | $905 | $27 |
| Gentamicin Sulfate | 14 | $897 | $64 |
| Tacrolimus | 12 | $826 | $69 |
| Benazepril | 79 | $810 | $10 |
| Carvedilol | 71 | $760 | $11 |
| Lisinopril | 41 | $506 | $12 |
| Simvastatin | 44 | $419 | $10 |
| Atenolol | 24 | $316 | $13 |
| Minoxidil | 17 | $250 | $15 |
| Lovastatin | 13 | $211 | $16 |
| Metoprolol | 22 | $205 | $9 |
| Terazosin | 12 | $195 | $16 |
| Warfarin | 14 | $176 | $13 |
| Dextrose in Water | 32 | $167 | $5 |
| Spironolactone | 19 | $131 | $7 |
| Hydrochlorothiazide | 17 | $123 | $7 |
| Clonidine | 13 | $113 | $9 |
| Clopidogrel | 19 | $99 | $5 |
2017: 47 drugs
| Renvela | 197 | $483,651 | $2,455 |
| Sensipar | 153 | $392,535 | $2,566 |
| Sevelamer Carbonate | 28 | $43,029 | $1,537 |
| Velphoro | 12 | $41,829 | $3,486 |
| Prosol | 140 | $33,244 | $237 |
| Uloric | 15 | $10,472 | $698 |
| Bumetanide | 40 | $6,202 | $155 |
| Atorvastatin | 200 | $5,657 | $28 |
| Intralipid | 26 | $4,820 | $185 |
| Advair Hfa | 12 | $4,437 | $370 |
| Chlorthalidone | 91 | $4,274 | $47 |
| Metoprolol | 92 | $3,755 | $41 |
| Calcitriol | 67 | $2,577 | $38 |
| Calcium Acetate | 33 | $2,461 | $75 |
| Irbesartan | 51 | $2,007 | $39 |
| Dextrose in Water | 44 | $1,991 | $45 |
| Nifedipine Er | 19 | $1,468 | $77 |
| Pravastatin | 49 | $1,434 | $29 |
| Torsemide | 38 | $1,422 | $37 |
| Valsartan | 19 | $1,306 | $69 |
| Allopurinol | 40 | $1,234 | $31 |
| Rosuvastatin | 11 | $1,191 | $108 |
| Furosemide | 178 | $1,162 | $7 |
| Tacrolimus | 13 | $1,047 | $81 |
| Lidocaine-Prilocaine | 30 | $978 | $33 |
| Metolazone | 12 | $977 | $81 |
| Benazepril | 98 | $967 | $10 |
| Amlodipine Besylate | 162 | $853 | $5 |
| Hydralazine | 32 | $764 | $24 |
| Carvedilol | 90 | $727 | $8 |
| Lovastatin | 19 | $677 | $36 |
| Gentamicin Sulfate | 16 | $667 | $42 |
| Losartan | 54 | $598 | $11 |
| Lisinopril | 42 | $547 | $13 |
| Simvastatin | 50 | $518 | $10 |
| Warfarin | 34 | $472 | $14 |
| Levothyroxine | 14 | $325 | $23 |
| Pantoprazole | 19 | $302 | $16 |
| Potassium Chloride | 12 | $283 | $24 |
| Prednisone | 17 | $256 | $15 |
| Atenolol | 34 | $215 | $6 |
| Spironolactone | 16 | $197 | $12 |
| Metoprolol | 22 | $126 | $6 |
| Clopidogrel | 17 | $105 | $6 |
| Hydrochlorothiazide | 18 | $102 | $6 |
| Minoxidil | 12 | $92 | $8 |
| Omeprazole | 16 | $75 | $5 |
2016: 48 drugs
| Renvela | 231 | $427,234 | $1,849 |
| Sensipar | 157 | $266,150 | $1,695 |
| Renagel | 20 | $51,263 | $2,563 |
| Velphoro | 23 | $47,651 | $2,072 |
| Prosol | 87 | $21,417 | $246 |
| Sildenafil | 12 | $9,562 | $797 |
| Uloric | 14 | $6,751 | $482 |
| Atorvastatin | 159 | $4,127 | $26 |
| Chlorthalidone | 86 | $3,782 | $44 |
| Bumetanide | 31 | $3,361 | $108 |
| Metoprolol | 81 | $3,355 | $41 |
| Pravastatin | 71 | $2,911 | $41 |
| Torsemide | 65 | $2,232 | $34 |
| Calcium Acetate | 19 | $1,905 | $100 |
| Clonidine | 13 | $1,857 | $143 |
| Dextrose in Water | 30 | $1,458 | $49 |
| Irbesartan | 36 | $1,406 | $39 |
| Nifedipine Er | 18 | $1,313 | $73 |
| Benazepril | 116 | $1,115 | $10 |
| Nifedical Xl | 23 | $1,059 | $46 |
| Calcitriol | 38 | $1,056 | $28 |
| Lidocaine-Prilocaine | 30 | $1,029 | $34 |
| Furosemide | 152 | $1,021 | $7 |
| Valsartan | 17 | $1,012 | $60 |
| Amlodipine Besylate | 133 | $996 | $7 |
| Midodrine | 21 | $853 | $41 |
| Potassium Chloride | 26 | $843 | $32 |
| Allopurinol | 29 | $687 | $24 |
| Lisinopril | 68 | $639 | $9 |
| Carvedilol | 73 | $602 | $8 |
| Losartan | 46 | $581 | $13 |
| Hydralazine | 23 | $536 | $23 |
| Levothyroxine | 22 | $513 | $23 |
| Fenofibrate | 12 | $509 | $42 |
| Lovastatin | 16 | $499 | $31 |
| Simvastatin | 75 | $470 | $6 |
| Spironolactone | 18 | $340 | $19 |
| Pantoprazole | 28 | $301 | $11 |
| Clopidogrel | 32 | $252 | $8 |
| Clonidine | 18 | $212 | $12 |
| Atenolol | 21 | $210 | $10 |
| Warfarin | 17 | $208 | $12 |
| Hydrochlorothiazide | 32 | $179 | $6 |
| Metoprolol | 19 | $153 | $8 |
| Minoxidil | 15 | $119 | $8 |
| Prednisone | 13 | $108 | $8 |
| Omeprazole | 14 | $107 | $8 |
| Glipizide | 17 | $84 | $5 |
2015: 49 drugs
| Renvela | 239 | $445,733 | $1,865 |
| Sensipar | 134 | $177,800 | $1,327 |
| Renagel | 38 | $86,675 | $2,281 |
| Fosrenol | 16 | $19,133 | $1,196 |
| Prosol | 82 | $14,555 | $177 |
| Crestor | 14 | $5,917 | $423 |
| Metoprolol | 93 | $4,972 | $53 |
| Chlorthalidone | 77 | $3,975 | $52 |
| Bumetanide | 23 | $3,945 | $172 |
| Valsartan | 26 | $3,808 | $146 |
| Atorvastatin | 118 | $2,864 | $24 |
| Pravastatin | 52 | $2,288 | $44 |
| Nifedipine Er | 28 | $2,058 | $73 |
| Clonidine | 12 | $1,964 | $164 |
| Telmisartan | 12 | $1,335 | $111 |
| Tacrolimus | 11 | $1,308 | $119 |
| Benazepril | 126 | $1,294 | $10 |
| Torsemide | 32 | $1,059 | $33 |
| Calcium Acetate | 13 | $935 | $72 |
| Irbesartan | 33 | $908 | $28 |
| Furosemide | 148 | $904 | $6 |
| Calcitriol | 27 | $857 | $32 |
| Carvedilol | 83 | $833 | $10 |
| Allopurinol | 35 | $799 | $23 |
| Amlodipine Besylate | 120 | $765 | $6 |
| Levothyroxine | 36 | $697 | $19 |
| Hydralazine | 25 | $692 | $28 |
| Potassium Chloride | 17 | $671 | $39 |
| Midodrine | 19 | $663 | $35 |
| Lidocaine-Prilocaine | 13 | $657 | $51 |
| Warfarin | 31 | $487 | $16 |
| Labetalol | 11 | $470 | $43 |
| Nifedical Xl | 11 | $447 | $41 |
| Pantoprazole | 28 | $444 | $16 |
| Simvastatin | 63 | $406 | $6 |
| Lovastatin | 23 | $355 | $15 |
| Lisinopril | 48 | $337 | $7 |
| Losartan | 25 | $320 | $13 |
| Clopidogrel | 38 | $310 | $8 |
| Clonidine | 25 | $281 | $11 |
| Spironolactone | 13 | $205 | $16 |
| Hydrochlorothiazide | 28 | $170 | $6 |
| Glipizide | 31 | $158 | $5 |
| Omeprazole | 18 | $157 | $9 |
| Metoprolol | 20 | $136 | $7 |
| Atenolol | 18 | $104 | $6 |
| Minoxidil | 11 | $78 | $7 |
| Tramadol | 11 | $74 | $7 |
| Zolpidem | 16 | $47 | $3 |
2014: 48 drugs
| Renvela | 263 | $321,512 | $1,222 |
| Sensipar | 162 | $204,838 | $1,264 |
| Renagel | 43 | $103,224 | $2,401 |
| Sevelamer Carbonate | 15 | $18,758 | $1,251 |
| Fosrenol | 11 | $8,828 | $803 |
| Diovan | 23 | $8,296 | $361 |
| Metoprolol | 129 | $6,510 | $50 |
| Nifedipine Er | 70 | $5,269 | $75 |
| Crestor | 15 | $3,874 | $258 |
| Prosol | 23 | $3,846 | $167 |
| Atorvastatin | 144 | $3,349 | $23 |
| Benicar | 16 | $3,111 | $194 |
| Lipitor | 12 | $2,838 | $236 |
| Chlorthalidone | 78 | $2,644 | $34 |
| Calcium Acetate | 14 | $2,249 | $161 |
| Irbesartan | 45 | $1,899 | $42 |
| Pravastatin | 39 | $1,446 | $37 |
| Bumetanide | 16 | $1,431 | $89 |
| Benazepril | 120 | $1,369 | $11 |
| Torsemide | 38 | $1,364 | $36 |
| Amlodipine Besylate | 146 | $1,341 | $9 |
| Carvedilol | 86 | $1,167 | $14 |
| Labetalol | 16 | $1,109 | $69 |
| Calcitriol | 31 | $1,074 | $35 |
| Hydralazine | 36 | $1,014 | $28 |
| Omeprazole | 40 | $927 | $23 |
| Pantoprazole | 18 | $801 | $45 |
| Losartan | 27 | $789 | $29 |
| Clopidogrel | 44 | $750 | $17 |
| Furosemide | 118 | $728 | $6 |
| Lisinopril | 82 | $551 | $7 |
| Simvastatin | 71 | $538 | $8 |
| Levothyroxine | 26 | $535 | $21 |
| Minoxidil | 24 | $391 | $16 |
| Hydrochlorothiazide | 31 | $384 | $12 |
| Warfarin | 25 | $382 | $15 |
| Allopurinol | 27 | $322 | $12 |
| Spironolactone | 18 | $297 | $17 |
| Hydrocodone-Acetaminophen | 17 | $293 | $17 |
| Metoprolol | 25 | $231 | $9 |
| Glipizide Er | 24 | $223 | $9 |
| Zolpidem | 29 | $214 | $7 |
| Tamsulosin | 13 | $184 | $14 |
| Glipizide | 25 | $162 | $6 |
| Clonidine | 14 | $156 | $11 |
| Fosinopril | 12 | $135 | $11 |
| Atenolol | 15 | $99 | $7 |
| Finasteride | 20 | $89 | $4 |
2013: 54 drugs
| Renvela | 268 | $273,656 | $1,021 |
| Sensipar | 200 | $193,420 | $967 |
| Renagel | 15 | $28,795 | $1,920 |
| Prosol | 94 | $16,078 | $171 |
| Diovan | 39 | $14,697 | $377 |
| Crestor | 29 | $7,503 | $259 |
| Nifedipine Er | 89 | $7,313 | $82 |
| Metoprolol | 112 | $6,755 | $60 |
| Atorvastatin | 150 | $5,449 | $36 |
| Irbesartan | 53 | $3,649 | $69 |
| Calcium Acetate | 21 | $3,442 | $164 |
| Benicar | 11 | $2,827 | $257 |
| Torsemide | 23 | $2,336 | $102 |
| Lipitor | 12 | $2,300 | $192 |
| Clopidogrel | 31 | $2,102 | $68 |
| Labetalol | 21 | $2,090 | $100 |
| Lidocaine-Prilocaine | 24 | $1,923 | $80 |
| Chlorthalidone | 78 | $1,728 | $22 |
| Amlodipine Besylate | 137 | $1,545 | $11 |
| Benazepril | 114 | $1,500 | $13 |
| Bumetanide | 36 | $1,416 | $39 |
| Nifedical Xl | 13 | $1,301 | $100 |
| Calcitriol | 27 | $1,188 | $44 |
| Hydralazine | 35 | $1,133 | $32 |
| Humulin N | 11 | $1,073 | $98 |
| Carvedilol | 72 | $1,053 | $15 |
| Furosemide | 124 | $1,019 | $8 |
| Simvastatin | 72 | $811 | $11 |
| Pravastatin | 25 | $786 | $31 |
| Minoxidil | 43 | $765 | $18 |
| Lisinopril | 79 | $765 | $10 |
| Warfarin | 27 | $616 | $23 |
| Omeprazole | 46 | $613 | $13 |
| Bisoprolol | 11 | $565 | $51 |
| Losartan | 19 | $502 | $26 |
| Isosorbide Mononitrate Er | 15 | $495 | $33 |
| Hydrocodone-Acetaminophen | 35 | $493 | $14 |
| Hydrochlorothiazide | 41 | $444 | $11 |
| Metoprolol | 56 | $425 | $8 |
| Clonidine | 41 | $378 | $9 |
| Lovastatin | 13 | $375 | $29 |
| Spironolactone | 22 | $370 | $17 |
| Sps | 11 | $311 | $28 |
| Glipizide Er | 23 | $274 | $12 |
| Levothyroxine | 22 | $273 | $12 |
| Allopurinol | 27 | $260 | $10 |
| Zolpidem | 32 | $249 | $8 |
| Quetiapine | 12 | $165 | $14 |
| Glipizide | 11 | $154 | $14 |
| Atenolol | 16 | $152 | $10 |
| Famotidine | 11 | $144 | $13 |
| Fosinopril | 11 | $131 | $12 |
| Mirtazapine | 12 | $109 | $9 |
| Citalopram Hbr | 12 | $107 | $9 |
Money from drug and device companies
$192 in 2025
| 2025 | 3 | 4 | None | $192 |
| 2024 | 1 | 1 | None | $35 |
| 2023 | 2 | 2 | None | $163 |
| 2022 | 2 | 2 | None | $33 |
| 2021 | 7 | 19 | None | $422 |
| 2020 | 4 | 15 | None | $268 |
| 2019 | 4 | 42 | None | $596 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $136 | 2 payments
|
| Akebia Therapeutics | Vafseo | $28 | 1 payment
|
| Novartis Pharmaceuticals | Fabhalta | $28 | 1 payment
|
See all 4 published payments
| Akebia Therapeutics | Meals · 2025-08-07 | Vafseo | $28 |
| Novo Nordisk | Meals · 2025-05-14 | Wegovy | $14 |
| Novo Nordisk | Meals · 2025-02-24 | Wegovy | $122 |
| Novartis Pharmaceuticals | Meals · 2025-01-10 | Fabhalta | $28 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $35
| Novartis Pharmaceuticals | Fabhalta | $35 | 1 payment
|
2023: $163
| Amgen | Aranesp | $149 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $14 | 1 payment
|
2022: $33
| Abbvie | Dalvance | $21 | 1 payment
|
| Vifor Pharma | Veltassa | $12 | 1 payment
|
2021: $422
| Amgen | Parsabiv | $105 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $85 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $85 | 4 payments
|
| Vifor Pharma | Veltassa | $64 | 3 payments
|
| Fresenius USA Marketing | Velphoro | $38 | 2 payments
|
| Abbott Laboratories | Cardiomems Hf System | $24 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $20 | 1 payment
|
2020: $268
| AstraZeneca Pharmaceuticals LP | Lokelma | $130 | 8 payments
|
| Otsuka America Pharmaceutical | Jynarque | $77 | 4 payments
|
| Amgen | Parsabiv | $46 | 2 payments
|
| Fresenius USA Marketing | Velphoro | $14 | 1 payment
|
2019: $596
| Relypsa | Veltassa | $236 | 30 payments
|
| Janssen Pharmaceuticals | Invokana | $135 | 7 payments
|
| Medtronic MiniMed | Minimed 670g System | $134 | 1 payment
|
| Amgen | Parsabiv | $91 | 4 payments
|
Professional record
- NPI
- 1225099286
- Licence
- CA A75956California A75956: Current · expires 2027-04-30
- Trained
- Yale University School of Medicine, 2000 · 26 years ago
- Group
- West Coast Kidney
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A759560
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 2149 E Warner Rd Ste 102, Tempe, AZ, 85284
- NPI first listed
- 2006-03-30
- NPI last updated
- 2019-08-26
This is when the NPI record was last certified, not a medical board exam.